Ro launches access to Eli Lilly's single-dose vials of GLP-1 Zepbound. Eli Lilly (LLY) concluded the recent trading session at $796.03, signifying a -0.44% move from its prior day's close.
After blind review by community volunteers of the initial Lilly Endowment Community Scholarship applications, nine finalists were selected — six young women and three young men. This year’s finalists ...
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor degrader (SERD), in patients with ...
One day removed from earning a tie for the No. 1 spot in the Class 3A Associated Press rankings, the Effingham Flaming Hearts had the challenge of facing a tough Mt. Vernon team, albeit at Effingham ...
Eli Lilly announces a $3 billion expansion at its Pleasant Prairie facility, creating 750 jobs. Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday.